M
Myron S. Cohen
Researcher at University of North Carolina at Chapel Hill
Publications - 576
Citations - 50913
Myron S. Cohen is an academic researcher from University of North Carolina at Chapel Hill. The author has contributed to research in topics: Population & Acquired immunodeficiency syndrome (AIDS). The author has an hindex of 103, co-authored 549 publications receiving 46021 citations. Previous affiliations of Myron S. Cohen include University of Massachusetts Medical School & Scripps Health.
Papers
More filters
Journal ArticleDOI
HIV treatment as prevention among people who inject drugs - a re-evaluation of the evidence.
Hannah Fraser,Christinah Mukandavire,Natasha K. Martin,Natasha K. Martin,Matthew Hickman,Myron S. Cohen,William C. Miller,Peter Vickerman +7 more
TL;DR: Observed declines in HIV incidence in Vancouver between 1996 and 2007 should be seen as a success for intensive harm reduction, whereas ART probably played a small role.
Journal ArticleDOI
Weighing the Evidence of Efficacy of Oral PrEP for HIV Prevention in Women in Southern Africa.
Holly Janes,Lawrence Corey,Lawrence Corey,Gita Ramjee,Lindsay N. Carpp,Carl Lombard,Myron S. Cohen,Peter B. Gilbert,Peter B. Gilbert,Glenda Gray +9 more
TL;DR: The need to continue to refine estimates of efficacy and effectiveness of tenofovir-based oral PrEP so as to best develop the next generation of HIV prevention tools, and to inform public policies directed toward HIV prevention is emphasized.
Journal ArticleDOI
Integrated syphilis/HIV screening in China: a qualitative analysis
Joseph D. Tucker,Li Gang Yang,Zheng Jun Zhu,Bin Yang,Yue Pin Yin,Myron S. Cohen,Xiang Sheng Chen +6 more
TL;DR: These STI case studies reveal the potential for expanding integrated syphilis/HIV services at public STI clinics in China and more health services research is needed to guide scale-up of syphilis and HIV testing in China.
Journal ArticleDOI
Prevention of the sexual transmission of HIV-1: preparing for success
TL;DR: Prevention of HIV requires decision-makers to focus resources on strategies that are most effective, and treatment of HIV and prevention of HIV must be considered and deployed together.
Journal ArticleDOI
Changes in HIV-1 Subtypes B and C Genital Tract RNA in Women and Men After Initiation of Antiretroviral Therapy
Susan A. Fiscus,Susan Cu-Uvin,Abel Tilahun Eshete,Michael Hughes,Yajing Bao,Mina C. Hosseinipour,Beatriz Grinsztejn,Sharlaa Badal-Faesen,Joan Dragavon,Robert W. Coombs,Ken Braun,Laura Moran,James Hakim,Timothy P. Flanigan,N. Kumarasamy,Thomas B. Campbell,Karin L. Klingman,Apsara Nair,Ann Walawander,Laura M. Smeaton,Victor De Gruttola,Ana Martinez,Edith Swann,Ronald L. Barnett,Barbara Brizz,Yvette Delph,Nikki Gettinger,Ronald T. Mitsuyasu,Susan H. Eshleman,Steven A. Safren,Adriana Andrade,David W. Haas,Farida Amod,Vladimir Berthaud,Robert C. Bollinger,Yvonne J. Bryson,David D. Celentano,David Chilongozi,Myron S. Cohen,Ann C. Collier,Judith S. Currier,Joseph J. Eron,Cynthia Firnhaber,Charles Flexner,Joel E. Gallant,Roy M. Gulick,Scott M. Hammer,Irving F. Hoffman,Peter N. Kazembe,Johnstone Kumwenda,Newton Kumwenda,Javier R. Lama,Jody Lawrence,Chiedza Maponga,Francis Martinson,Kenneth H. Mayer,Karin Nielsen,Richard B. Pendame,Bharat Ramratnam,James F. Rooney,Jorge Sanchez,Ian Sanne,Robert T. Schooley,Wendy Snowden,Suniti Solomon,Steve Tabet,Taha E. Taha,Jonathan Uy,Charles van der Horst,Christine Wanke,Joan Gormley,Cheryl Marcus,Beverly Putnam,Smanga Ntshele,Edde Loeliger,Keith A. Pappa,Nancy Webb,David Shugarts,Mark A. Winters,Renard S. Descallar,Jabin Sharma,S. Poongulali,Sandra W. Cardoso,Deise Lucia Faria,Sima Berendes,Kelly Burke,Cecelia Kanyama,Virginia Kayoyo,Wadzanai Samaneka,Anthony Chisada,Breno Santos,Alberto La Rosa,Rosa Infante,Henry H. Balfour,Beth D. Mullan,Ge-Youl Kim,Michael K. Klebert,Donna Mildvan,M. P. Revuelta,P. Jan Geiseler,Bartolo Santos,Eric S. Daar,Ruben Lopez,Laurie Frarey,David Currin,David H. Haas,Vicki L. Bailey,Pablo Tebas,Larisa Zifchak,Beverly E. Sha,Janice M. Fritsche +110 more
TL;DR: The female genital tract may serve as a reservoir of persistent HIV-1 replication during cART and affect the use of cART to prevent sexual and perinatal transmission of HIV- 1.